Yoshiyuki Yamamoto

5PUBLICATIONS
66CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 27, 2026
Phase II study of mFOLFOX6 in advanced gastric cancer patients with severe peritoneal metastases (WJOG10517G), including an individual patient data comparison with JCOG1108/WJOG7312G.

|Feb 02, 2026
ANGPTL3 in the Peripheral Circulation Is Associated with Resistance to Anti-PD1 Therapy in Advanced Gastric Cancer.

Chie Kudo-Saito, Hirokazu Shoji, Kengo Nagashima

|Sep 10, 2024
Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.

Jun Hamano, Takahiro Higashibata, Takaomi Kessoku

|Feb 21, 2022
Clinical Validity of Plasma-Based Genotyping for Microsatellite Instability Assessment in Advanced GI Cancers: SCRUM-Japan GOZILA Substudy.

Yoshiaki Nakamura, Wataru Okamoto, Tadamichi Denda

|Aug 11, 2021
Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer.

Tomoko Jogo, Yoshiaki Nakamura, Kohei Shitara

Pageof 1

Frequent Collaborators

2 joint publications

Hideaki Bando

2 joint publications

Taroh Satoh

2 joint publications

Yu Sunakawa

2 joint publications

Eiji Oki